fsp1 is a glutathione-independent ferroptosis suppressor Proposed model for the catalytic and anti-ferroptotic mechanism of Unleashing Ferroptosis in Human Cancers:

Another study also confirmed the importance of intestinal flora

Application of this model could potentially lead to pioneering strategies to counteract or treat age-related muscle atrophy and impaired regeneration with fibrosis and fat infiltration (including sarcopenia and frailty)

[DOI] [PubMed] [Google Scholar] 34.Han H, Yu Q, Qin N, Song B, Meng Y, Feng Z, Li Z, Chen L

The peptide complex restores extracellular matrix homeostasis by increasing the synthesis and turnover of collagen, elastin, and glycosaminoglycans, as well as by modulating the balance between metalloproteinases (MMPs) and their inhibitors (TIMPs), thus supporting both matrix remodeling and scar resolution 2,3

BPC-157 was designated as a Category 2 bulk drug substance in 2023, restricting its use in compounding pharmacies

tritici (Ggt) on the roots